Page last updated: 2024-11-01

nitrendipine and Eaton-Lambert Myasthenic Syndrome

nitrendipine has been researched along with Eaton-Lambert Myasthenic Syndrome in 2 studies

Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meriney, SD1
Hulsizer, SC1
Lennon, VA1
Grinnell, AD1
Peers, C1
Lang, B1
Newsom-Davis, J1
Wray, DW1

Other Studies

2 other studies available for nitrendipine and Eaton-Lambert Myasthenic Syndrome

ArticleYear
Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
    Annals of neurology, 1996, Volume: 40, Issue:5

    Topics: Autoantibodies; Barium; Calcium Channel Blockers; Calcium Channels; Carcinoma, Small Cell; Cell Cycl

1996
Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line.
    The Journal of physiology, 1990, Volume: 421

    Topics: Action Potentials; Animals; Antibodies, Neoplasm; Calcium Channels; Cell Line; Glioma; Humans; Immun

1990